To understand the role of DUBs in NSCLCs, we analyzed the expression levels of USP21 in LC patients using the lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) data set of The Cancer Genome Atlas (TCGA). The gene discussed is USP21; the disease is laryngotracheoesophageal cleft.